Home › Funds › BROWN CAPITAL MANAGEMENT LLC › RGEN

BROWN CAPITAL MANAGEMENT LLC position in RGEN

Repligen Corp · Health Care

BROWN CAPITAL MANAGEMENT LLC reported holding 84,554 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$16.3M, representing 3.08% of its reported portfolio and ranking #11 among its reported holdings. BROWN CAPITAL MANAGEMENT LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)84.55K sh
Reported value held$16.25M
Portfolio Weight3.08%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROWN CAPITAL MANAGEMENT LLC's RGEN position evolved

BROWN CAPITAL MANAGEMENT LLC first disclosed a stake in RGEN in Q3 2023 at 1,441,648 shares (US$229.2M). The position peaked in Q4 2023 at 1,525,064 shares, worth US$274.2M. Across 13 filings, BROWN CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 84,554 shares valued at US$16.3M — a reduction of -56,345 shares quarter over quarter.. Notable position changes include a 59% trim in Q4 2025 (shares fell 28% over the following quarter), a 38% trim in Q1 2026 (shares rose 16% over the following quarter), a 40% trim in Q3 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.44M $229.24M New
Q4 2023 1.53M $274.21M Add
Q1 2024 1.15M $212.36M Reduce
Q2 2024 1.29M $163.08M Add
Q3 2024 1.12M $166.62M Reduce
Q4 2024 954.94K $137.45M Reduce
Q1 2025 864.03K $109.94M Reduce
Q2 2025 1.01M $125.04M Add
Q3 2025 668.86K $89.41M Reduce
Q4 2025 273.97K $44.89M Reduce
Q1 2026 170.00K $20.03M Reduce
Q2 2026 140.90K $19.22M Reduce
Q3 2026 84.55K $16.25M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has BROWN CAPITAL MANAGEMENT LLC held RGEN?

BROWN CAPITAL MANAGEMENT LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BROWN CAPITAL MANAGEMENT LLC's current position in RGEN?

As of Q3 2026, BROWN CAPITAL MANAGEMENT LLC holds 84.55K shares of RGEN (Repligen Corp), valued at $16.25M, representing 3.08% of its reported portfolio and ranking #11.

Has BROWN CAPITAL MANAGEMENT LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), BROWN CAPITAL MANAGEMENT LLC reduced its position in RGEN. The position peaked in Q4 2023 at 1.53M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.